We conducted a multicenter clinical validity study of the Panbio COVID-19 Antigen Rapid Test of nasopharyngeal samples in pediatric patients with COVID-19 compatible symptoms of =5 days of evolution. Our study showed limited accuracy in nasopharyngeal antigen testing:
